The National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Genedata (Usa), Inc. for $25,900 on September 22, 2026, for renewal of Genedata Analyst bioinformatics software. Performance occurs at Bethesda, Maryland. The award is firm fixed price with no set-aside designation. Genedata Analyst supports the Viral Pathogenesis and Evolution Section's statistical modeling and visualization of multi-omics data—gene expression, transcriptomics, and proteomics—derived from vaccine and infection studies. The software enables normalization, parametric and non-parametric statistical testing, principal components analysis, mixed linear models, machine learning, and interactive visualization including heat maps, scatter plots, and specialized statistical viewers. This is a sole-source renewal supporting over eight years of accumulated clinical and experimental vaccine development research. Ultimate completion date is September 21, 2027.